Can a quick chat with a radiotherapy tech ease cancer patients' anxiety?
NCT ID NCT02867462
First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 3 times
Summary
This study looked at whether having a special consultation with a radiotherapy technician (called a manipulator) helps cancer patients feel more informed about their treatment. Researchers enrolled 308 adults with various cancers who were getting radiation therapy. They compared standard care to standard care plus this extra consultation, measuring how much information patients felt they received using a questionnaire.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If it works, this could show that a simple extra chat with a radiotherapy technician helps cancer patients feel better informed and less anxious.
- What could go wrong
- This is a completed study that only measures patient-reported information levels, not treatment outcomes. The results may not change medical practice or directly improve health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
308 people
The number who actually took part.
- Started
-
Apr 2013
- Finished
-
May 2017
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with cancer of the head and neck, esophagus, stomach, breast, rectum, anal canal, prostate, lung, bile duct, pancreas or female genital histologically proven * Patient being treated by radiotherapy alone or combined with chemotherapy / immunotherapy, exclusive treatment or adjuvant * Age over 18 years Exclusion Criteria: * Patient has been treated with radiation to the tumor site * Patient with metastatic stage disease * Patient targeted for hypofractionated radiotherapy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anal canal cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Antoine LACASSAGNE
Nice, 0, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Gut bacteria may hold clues to dozens of diseases
- Radioactive missile aims at prostate cancer that spread
- Surgeons could freeze lung tumors from miles away using 5G robots
- Can High-Risk breast cancer patients skip an extra radiation boost?
- New PET tracer targets ACP3 to spot prostate cancer